KEY TAKEAWAY: According to the World Health Organization (WHO), the number of people living with diabetes has quadrupled since 1980, growing to more than 400 million. And with this rise in disease, sales of diabetes-related products have also climbed. In fact, in 2015, American consumers spent $592 million on such products.The cost of diabetes drugs rose 150 percent for six popular, brand-name diabetes drugs in the past five years. Two of these drugs rose in price more than 250 percent. Continue reading “Diabetes drug costs”
KEY TAKEAWAY: The biggest threat to healthcare is not drug pricing, it’s ourselves. Research from the American Diabetes Association shows the total cost of diabetes was $245 billion in 2012 — a 41% increase from the $174 billion spent in 2007.
Continue reading “The cost of diabetes in America is $245 billion”
POST SUMMARY: The total estimated cost of diagnosed diabetes in 2012 is $245 billion, including $176 billion in direct medical costs and $69 billion in reduced productivity. The largest components of medical expenditures are: hospital inpatient care (43% of the total medical cost). Here is a story of one person.. Continue reading “The staggering cost of diabetes”
The world is losing the battle against diabetes as the number of people estimated to be living with the disease soars to a new record of 382 million this year. Diabetic retinopathy affects about 28.5 percent of Americans with diabetes age 40 and older. That’s more than 7 million people, and the number is expected to reach more than 11 million by the year 2030. Continue reading “November: National Diabetes Month”
The world is losing the battle against diabetes as the number of people estimated to be living with the disease soars to a new record of 382 million this year, medical experts said on Thursday. The vast majority have type 2 diabetes – the kind linked to obesity and lack of exercise – and the epidemic is spreading as more people in the developing world adopt Western, urban lifestyles. By 2035, the organization predicts the number of cases will have soared by 55 percent to 592 million. While pharma targets cancer drugs as a way to replace products coming off patent there seems to be a huge opportunity in the diabetes market. Continue reading “The next cash cow: diabetes ?”